Lenacapavir Demonstrates Small Margin of Resistance for Those Heavily Treated With HIV
October 25th 2023Patients with HIV who were resistant to treatment with lenacapavir (Sunlenca; Gilead Sciences Inc) were found to have inadequate adherence to optimized background regimen or did not have a fully active antiretroviral.
Read More
Independent Rx Forum - NCPA Conference: Legal Update on PBM Litigation
October 24th 2023Jack Mozloom, vice president of Public Affairs at the National Community Pharmacists Association (NCPA), speaks with Matt Seiler, general counsel at NCPA, about the current PBM litigation at the 2023 NCPA Convention.
Listen
CDC Issues Alert to Address Shortage of RSV Treatment Nirsevimab
October 24th 2023Nirsevimab-alip (Beyfortus; Sanofi and AstraZeneca) is a monoclonal antibody approved to prevent against respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants under 8 months of age born during or entering their first RSV season.
Read More
Celebrating Pharmacists: The Evolution of Pharmacy From Beyond the Counter
October 24th 2023Vanessa Campbell, PharmD, the director of Clinical Pharmacy at UPMC Health Plan, discusses her role and responsibilities, which include managing a team of pharmacists involved in patient outreach and clinical disease state management.
Watch
How Pharmacy Curricula Should Adjust to Abortion Legislature
Curricula should require comprehensive training for providing contraceptive care, helping students perform duties confidently and competently.
Read More